Taysha Gene Therapies
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TSHA and other ETFs, options, and stocks.About TSHA
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing.
TSHA Key Statistics
Stock Snapshot
The current Taysha Gene Therapies(TSHA) stock price is $6.66, with a market capitalization of 1.91B. The stock trades at a price-to-earnings (P/E) ratio of -18.42.
On 2026-05-05, Taysha Gene Therapies(TSHA) stock moved within a range of $6.60 to $6.81. With shares now at $6.66, the stock is trading +0.9% above its intraday low and -2.3% below the session's peak.
Trading volume for Taysha Gene Therapies(TSHA) stock has reached 376.67K, versus its average volume of 2.18M.
The stock's 52-week range extends from a low of $1.85 to a high of $6.81.
The stock's 52-week range extends from a low of $1.85 to a high of $6.81.
Analyst ratings
100%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.